SCHEMBL3216043

SCHEMBL3216043

CCOc1cc(N(Cc2cocn2)c2ccc(C(=O)OC)cc2)ccc1OC(F)F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
LMNA P02545 2/20 0.41
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
RAB9A P51151 3/20 0.39
HTT P42858 2/20 0.39
KDM4E B2RXH2 1/20 0.39
GLA P06280 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
NAMPT P43490 1/20 0.39
HRH4 Q9H3N8 2/20 0.37
TSHR P16473 2/20 0.37
USP2 O75604 1/20 0.37
PDE4D Q08499 3/20 0.35
PDE4A P27815 2/20 0.35
PDE4B Q07343 2/20 0.35
PDE4C Q08493 2/20 0.35
CREBBP Q92793 1/20 0.35
ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3129483 0.91 RXRA (0.44) MEN1KMT2ALMNAMAPTMAPK1
SCHEMBL3215031 0.90 KMT2A (0.38) MEN1KMT2ALMNAMAPTMAPK1
SCHEMBL3249805 0.77 PDE4B (0.32) MEN1KMT2ALMNAMAPTMAPK1
SCHEMBL3131505 0.76 PDE4D (0.40) MEN1KMT2ALMNAMAPTMAPK1
SCHEMBL28033776 0.76 KMT2A (0.56) MEN1KMT2ALMNAMAPTMAPK1
SCHEMBL3215299 0.75 HDAC6 (0.37) MEN1KMT2ALMNAMAPTMAPK1
SCHEMBL3128010 0.75 RXRA (0.43) MEN1KMT2ALMNAMAPTMAPK1
SCHEMBL3120590 0.75 LMNA (0.38) MEN1KMT2ALMNAMAPTMAPK1
SCHEMBL3126123 0.74 HRH4 (0.38) MEN1KMT2ALMNAMAPTMAPK1
SCHEMBL3214115 0.74 KMT2A (0.37) MEN1KMT2ALMNAMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS PDE4A, PDE4B, PDE3B MEN1 3385/4885KMT2A 1324/4885LMNA 3769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.